PURE Bioscience Q1 FY2025 product sales $555K, down 23% YoY; net loss per share ($0.01)

PURE BIOSCIENCE, INC.

2025-Q1 EPS reported -$0.01 revenue$555,000

Net product sales of $555K for quarter ended Oct 31, 2024, vs $718K YoY, due to budget constraints of a large end-use customer.
Net loss narrowed to $689K from $735K YoY; net loss per share unchanged at ($0.01).
Excluding share-based compensation, net loss was $632K vs $655K YoY.
CEO cites unexpected interruption in product flow to a major customer and lack of replacement revenue as reasons for the decline.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.